#SFHS2608438AOrder of March 25, 2026, regarding the renewal and modification of the listing conditions for the ORION 3 microprocessor-controlled hydropneumatic mono-axial knee from BLATCHFORD company
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law updates the conditions under which the ORION 3 knee prosthesis by BLATCHFORD is reimbursed in France, extending its coverage until April 15, 2030. It allows for additional prosthetic foot options for use with the ORION 3, enhancing flexibility for users. Professionals dealing with medical device reimbursement should take note of these changes.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Extension of reimbursement coverage for ORION 3 until April 2030
- Inclusion of additional foot options for ORION 3
- Flexibility enhancements for prosthetic adaptations
Obligations
What this law requires
Update reimbursement listings to reflect that ORION3 knee prosthesis can be paired with energy-return feet of class II or III OR hydraulic ankle prosthetic feet (ECHELON model), replacing the previous restriction to class II or III feet only
Extend reimbursement coverage for ORION3 microprocessor-controlled mono-axial knee (code 2790696) until April 15, 2030
Extend reimbursement coverage for ORION3 revision procedures (code 2732702) until April 15, 2030
Ensure only the four specified proximal adapters are covered: 239017, 189128, 139092, and 239089, as listed in the updated reimbursement references
Apply this order effective 13 days following publication in the Journal officiel de la République française